First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
Status:
Completed
Trial end date:
2018-10-03
Target enrollment:
Participant gender:
Summary
This clinical trial is the first-in-human study of BBT-401-1S. The purpose of this phase 1
study is to assess the safety and tolerability of single and multiple ascending oral doses of
BBT-401-1S in healthy adult subjects.